+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Caspofungin Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2019-2027

  • ID: 4852055
  • Report
  • April 2019
  • Region: Global
  • 156 pages
  • Transparency Market Research
1 of 2

Caspofungin Market: Overview

This report on the global caspofungin market analyzes the current and future prospects of the market. The report comprises a comprehensive executive summary, including a snapshot that provides overall information of various market segments. The research is a combination of primary and secondary researches. Primary research formed the bulk of the research efforts along with information collected from telephonic interviews and interactions via e-mails. Secondary research involved study of company websites, annual reports, press releases, stock analysis presentations, and various international and national databases. The report provides market size in terms of US$ Mn for each segment for the period from 2017 to 2027, considering the macro and micro environmental factors. Growth rate for each segment of the global caspofungin market has been determined after a thorough analysis of past trends, demographics, future trends, technological developments, and regulatory requirements.

A detailed qualitative analysis of factors responsible for driving and restraining the market and opportunities has been provided in the overview section. The report also provides insights into the key trends of the caspofungin market. The report includes market attractiveness analysis of the major segments that provides a thorough analysis of the overall competitive scenario in the global caspofungin market.

Market revenue in terms of US$ Mn for the period between 2017 and 2027 along with the compound annual growth rate (CAGR %) from 2019 to 2027 are provided for all the segments, considering 2018 as the base year. The year-on-year growth of the global caspofungin market for each segment is also reflected. Additionally, market-related factors such as favorable reimbursement scenario, expanding distribution channels of caspofungin, and historical year-on-year growth have been taken into consideration while estimating the market size.

Global Caspofungin Market: Key Segments

Based on indication, the global caspofungin market has been segmented into candidiasis and thrush. In terms of distribution channel, the global market has been classified into hospital pharmacies, retail pharmacies, and online pharmacies.

Global Caspofungin Market: Regional Outlook

In terms of region, the global caspofungin market has been segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. Additionally, the regions have been divided into major countries/sub-regions. These include the U.S., Canada, the U.K., Germany, France, Italy, Spain, China, Australia & New Zealand, Japan, India, Brazil, GCC Countries, South Africa, Israel, and Mexico.

Companies Mentioned in Report

The report also profiles major players in the global caspofungin market based on various attributes such as company overview, financial overview, SWOT analysis, key business strategies, product portfolio, and recent developments. Key companies profiled in the report include Teva Pharmaceutical Industries Ltd., Mylan N.V , Merck & Co., Inc., Fresenius SE & Co. KGaA, Gland Pharma Limited, Xellia Pharmaceuticals, and Novartis AG.

Note: Product cover images may vary from those shown
2 of 2
Section 1 Preface
1.1 Report Scope and Market Segmentation
1.2 Research Highlights

Section 2 Assumptions and Research Methodology
2.1 Assumptions
2.2 Research Methodology

Section 3 Executive Summary
3.1 Global Caspofungin Market Snapshot
3.2 Key Industry Developments

Section 4 Market Overview
4.1 Caspofungin Market Taxonomy
4.2 Caspofungin Drug Introduction
4.3 Global Caspofungin Market Size (US$ Mn) Forecast, 2017-2027
4.4 Global Caspofungin Market: Market Outlook
4.5 Rise in incidence of invasive candidiasis across the globe
4.5.1.Rise in geriatric population
4.5.2.Advantages of echinocandins over other antifungal
4.5.3.Restraints
4.5.3.1 Availability of Generic Drugs
4.5.3.2 Emergence of resistant species
4.5.4 Opportunities
4.5.4.1 Echinocandins, as first line of therapy in candidiasis
4.5.4.2 Expansion of Research and Development in Emerging Markets

Section 5 Key Insights
5.1 Clinical Trial Pipeline Analysis
5.2 Disease Prevalence & Incidence Rate globally with key countries
5.3 Supply Chain Analysis
5.4 Pricing Analysis by Manufacturers

Section 6 Global Caspofungin Market Analysis, by Indication
6.1 Key Findings
6.2 Introduction
6.3 Market Value Share Analysis, by Indication
6.4 Market Value Forecast, by Indication, 2017-2027
6.5 Market Analysis, by Indication, 2017-2027
6.5.1 Candidiasis
6.5.2 Thrush
6.6 Market Attractiveness, by Indication

Section 7 Global Caspofungin Market Analysis, by Distribution Channel
7.1 Key Findings
7.2 Introduction
7.3 Market Value Share Analysis, by Distribution Channel
7.5.1. Hospital Pharmacies
7.5.2 Retail Pharmacies
7.5.3 Online Pharmacies
7.6 Market Attractiveness, by Distribution Channel

Section 8 Global Caspofungin Market Analysis, by Region
8.1 Market Value Share Analysis, by Region
8.2 Market Forecast, by Region
8.3 Global Caspofungin Market Attractiveness Analysis, by Region

Section 9 North America Caspofungin Market Analysis
9.1 Market Overview
9.2 Market Value Share Analysis, by Indication
9.3 Caspofungin Market Forecast, by Indication
9.4 Market Value Share Analysis, by Distribution Channel
9.5 Caspofungin Market Forecast, by Distribution Channel
9.6 U.S.
9.6.1 Canada
9.7 Market Attractiveness Analysis
9.7.1 By Country
9.7.2 By Indication
9.7.3 By Distribution Channel

Section 10 Europe Caspofungin Market Analysis
10.1 Market Overview
10.2 Market Value Share Analysis, by Indication
10.3 Caspofungin Market Forecast, by Indication
10.4 Market Value Share Analysis, by Distribution Channel
10.5 Caspofungin Market Forecast, by Distribution Channel
10.6 Market Value Share Analysis, by Country/Sub-region
10.7 Market Forecast, by Country/Sub-region
10.7.1 Germany
10.7.2 U.K.
10.7.3 France
10.7.4 Spain
10.7.5 Italy
10.7.6 Rest of Europe
10.8 Market Attractiveness Analysis
10.8.1 By Country/Sub-region
10.8.2 By Indication
10.8.3 By Distribution Channel

Section 11 Asia Pacific Caspofungin Market Analysis
11.1 Market Overview
11.2 Market Value Share Analysis, by Indication
11.3 Caspofungin Market Forecast, by Indication
11.4 Market Value Share Analysis, by Distribution Channel
11.5 Caspofungin Market Forecast, by Distribution Channel
11.6 Market Value Share Analysis, by Country/Sub-region
11.7 Market Forecast, by Country/Sub-region
11.7.1 China
11.7.2 Japan
11.7.3 India
11.7.4 Australia & New Zealand
11.7.5 Rest of Asia Pacific
11.8 Market Attractiveness Analysis
11.8.1 By Country/Sub-region
11.8.2 By Indication
11.8.3 By Distribution Channel

Section 12 Latin America Caspofungin Market Analysis
12.1 Market Overview
12.2 Market Value Share Analysis, by Indication
12.3 Caspofungin Market Forecast, by Indication
12.4 Market Value Share Analysis, by Distribution Channel
12.5 Caspofungin Market Forecast, by Distribution Channel
12.6 Market Value Share Analysis, by Country/Sub-region
12.7 Market Forecast, by Country/Sub-region
12.7.1 Brazil
12.7.2 Mexico
12.7.3 Rest of Latin America
12.8 Market Attractiveness Analysis
12.8.1 By Country/Sub-region
12.8.2 By Indication
12.8.3 By Distribution Channel

Section 13 Middle East & Africa (MEA) Caspofungin Market Analysis
13.1 Market Overview
13.2 Market Value Share Analysis, by Indication
13.3 Caspofungin Market Forecast, by Indication
13.4 Market Value Share Analysis, by Distribution Channel
13.5 Caspofungin Market Forecast, by Distribution Channel
13.6 Market Value Share Analysis, by Country/Sub-region
13.7 Market Forecast, by Country/Sub-region
13.7.1 GCC Countries
13.7.2 South Africa
13.7.3 Israel
13.7.4 Rest of MEA
13.8 Market Attractiveness Analysis
13.8.1 By Country/Sub-region
13.8.2 By Indication
13.8.3 By Distribution Channel

Section 14 Company Profiles
14.1 Market Player - Competition Matrix (By Tier and Size of companies)
14.2 Market Share Analysis, by Company, 2017
14.3 Company Profile
14.3.1 Teva Pharmaceutical Industries Ltd.
14.3.1.1 Company Overview (HQ, Business Segments, Employee Strength)
14.3.1.2 Financial Overview
14.3.1.3 Product Portfolio
14.3.1.4 SWOT Analysis
14.3.1.5 Strategic Overview
14.3.2 Novartis AG
14.3.2.1 Company Overview (HQ, Business Segments, Employee Strength)
14.3.2.2 Financial Overview
14.3.2.2 Product Portfolio
14.3.2.3 SWOT Analysis
14.3.2.4 Strategic Overview
14.3.3 Mylan N.V.
14.3.3.1 Company Overview (HQ, Business Segments, Employee Strength)
14.3.3.2 Financial Overview
14.3.3.3 Product Portfolio
14.3.3.4 SWOT Analysis
14.3.3.5 Strategic Overview
14.3.4 Merck & Co., Inc.
14.3.4.1 Company Overview (HQ, Business Segments, Employee Strength)
14.3.4.2 Financial Overview
14.3.4.2 Product Portfolio
14.3.4.3 SWOT Analysis
14.3.4.4 Strategic Overview
14.3.5 Fresenius SE & Co. KGaA
14.3.5.1 Company Overview (HQ, Business Segments, Employee Strength)
14.3.5.2 Financial Overview
14.3.5.2 Product Portfolio
14.3.5.3 SWOT Analysis
14.3.5.4 Strategic Overview
14.3.6 Gland Pharma Limited (Shanghai Fosun Pharmaceutical (Group) Co., Ltd.)
14.3.6.1 Company Overview (HQ, Business Segments, Employee Strength)
14.3.6.2 Financial Overview
14.3.6.3 Product Portfolio
14.3.6.4 SWOT Analysis
14.3.6.5 Strategic Overview
14.3.7 Xellia Pharmaceuticals
14.3.7.1 Company Overview (HQ, Business Segments, Employee Strength)
14.3.7.2 Financial Overview
14.3.7.3 Product Portfolio
14.3.7.4 SWOT Analysis
14.3.7.5 Strategic Overview
Note: Product cover images may vary from those shown
3 of 2

Loading
LOADING...

Adroll
adroll